openPR Logo
Press release

Biosimulation Market - Accelerated drug discovery development process by key players to favor market growth

09-10-2019 01:37 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Biosimulation Market

Biosimulation Market

Modeling and simulation (M&S) in the drug development process is a scientific approach used in crucial drug development decisions. In order to avoid issues in discovery and development of new drug, biosimulation offers a promising tool, along with saving both time, money, and improving the predictability in early stage of drug development. Biosimulation refers to simulation of biological systems.

Get Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/2016

FDA also utilizes M&S in the drug development process. FDA’s Center for Drug Evaluation and Research (CDER) is currently using modeling and simulation to predict clinical outcomes, inform clinical trial designs, support evidence of effectiveness, optimize dosing, predict product safety, and evaluate potential adverse event mechanisms. Biosimulation is important for drug development, as it provides information regarding dose precision, drug-drug interaction on a molecular level, as well as physiologically-based pharmacokinetic (PBPK) modelling using sophisticated pharmacodynamics models of the heart, liver, and other systems. In addition to this, according to the US FDA’s Office of Clinical Pharmacology (OCP), 2014 data, PBPK modelling: a mathematical predictions of drug interactions with other drugs is increasingly used by FDA in drug discovery and early development process. Moreover, growing adoption of biosimulation tools in various stages of drug development help to increase growth of the biosimulation market

The global biosimulation market size was valued at US$ 1,323.1 Mn in 2017 and is expected to witness a CAGR of 15.4% over the forecast period (2018 – 2026).

Accelerated drug discovery development process by key players to favor market growth

Pharmaceutical companies, non-profit organizations, and healthcare regularity organizations are majorly investing in research and development of drug discovery process. Market players are engaged in exploiting biosimulation techniques for enhancing efficacy of drug discovery and development process, which is expected to drive growth of the biosimulation market. Government of various economies are funding initiatives such as Innovate UK and Horizon 2020 provide businesses and research organizations with grants to drive scientific research. Innovate UK is the UK’s innovation agency and part of UK Research and Innovation, which supported two companies, Adorial Pharma Limited and C4X Discovery, in enabling the development of a novel mathematical-based system of drug discovery. Moreover, in March 2016, C4X Discovery Holdings plc., an innovative drug discovery and development organization announced acquisition of Adorial Limited. Combining these two business, along with support by Innovative UK will accelerate commercial and clinical success of biosimulation.

Key players operating in biosimulation market include Certara, L.P., Simulations Plus, Inc., Dassault Systèmes (Accelrys), Genedata AG, LeadScope, Inc., Compugen Inc., Schrödinger, LLC, In Silico Biosciences, Inc., Advanced Chemistry Development, Inc., Chemical Computing Group ULC, Physiomics PLC, and Pharmaceutical Product Development, LLC (Evidera).

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/2016

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biosimulation Market - Accelerated drug discovery development process by key players to favor market growth here

News-ID: 1831599 • Views: 187

More Releases from Coherent Market Insights

Industrial Water Management Market To Rise Demand, Analysis By Revenue of Top Pl …
Industrial water management involves deployment of sustainable solutions for water and wastewater management in industries to ensure optimum utilization of fresh water sources and of water conservation. These solutions aid companies to reduce adverse environmental impacts, enhance their internal workflow processes with optimum costs, and adhere to stringent regional regulations. These solutions have environmental, social, and economic benefits and this is expected to aid the companies in the near future. Download
Sarcopenia Treatment Market In-depth Study 2019: GlaxoSmithKline, Radius Health …
Coherent Market Insights Market Reports offers 2019 Depth Insights report on Global Sarcopenia Treatment market that evaluates industry growth trends, through historical data and estimates future prospects based on comprehensive research. The report also identifies the factors driving this market, various restraints and opportunities impacting it along with the adoption trends for the period 2018-2026. The Sarcopenia Treatment market research report displays the latest industry insights with future trends and analysis
Testosterone Replacement Therapy Market Boosting Growth By Top Players AbbVie, I …
Coherent Market Insights Market Reports offers 2019 Depth Insights report on Global Testosterone Replacement Therapy market that evaluates industry growth trends, through historical data and estimates future prospects based on comprehensive research. The report also identifies the factors driving this market, various restraints and opportunities impacting it along with the adoption trends for the period 2018-2026. The Testosterone Replacement Therapy market research report displays the latest industry insights with future trends
Hepatitis C Drugs Market 2019 | Rapid Growth by Players Merck & Co. Inc., Vertex …
Coherent Market Insights Market Reports offers 2019 Depth Insights report on Global Hepatitis C Drugs market that evaluates industry growth trends, through historical data and estimates future prospects based on comprehensive research. The report also identifies the factors driving this market, various restraints and opportunities impacting it along with the adoption trends for the period 2018-2026. The Hepatitis C Drugs market research report displays the latest industry insights with future trends

All 5 Releases


More Releases for Biosimulation

Biosimulation Market Growth and Sales Forecast 2016 - 2014
Global Biosimulation Market: Overview Biosimulation refers to the mathematical simulation of biological processes and systems. It is aided by computer and is used for model based calculation of biological systems and processes. TMR’s latest report forecasts strong growth for the global biosimulation market between 2011 and 2018. The market is expected to significantly gain from the increasing use of pharmacokinetic (PKPD) and pharmacodynamics, of which PKPD is the most widely used
North America to Dominate the Global Biosimulation Market
Market Research Reports Search Engine (MRRSE) has added a new report in its repository titled‘Biosimulation Market: Global Industry Analysis (2012-2016) and Forecast (2017-2022)’. This report presents in-depth insights on the global biosimulation market over the forecast period 2017-2022. To precisely estimate the market value share and volume forecast, the report gauges 2016 as the base year. Moreover, to present a comprehensive forecast of the market, the report provides information on the various factors
North America to Dominate the Global Biosimulation Market
Market Research Reports Search Engine (MRRSE) has added a new report in its repository titled‘Biosimulation Market: Global Industry Analysis (2012-2016) and Forecast (2017-2022)’. This report presents in-depth insights on the global biosimulation market over the forecast period 2017-2022. To precisely estimate the market value share and volume forecast, the report gauges 2016 as the base year. Moreover, to present a comprehensive forecast of the market, the report provides information on the various factors
Biosimulation Market 2025 Share, Growth and Regional Forecast
Crystalmarketresearch.com published “Biosimulation Market By Product, Application, And End User - Global Industry Analysis And Forecast To 2025” from its database. The report reviews top companies involved and enlists all trials pertaining to the company. The biosimulation market is expected to be around $4 billion by 2025. This growth can be attributed to number of factors such as rise in incidence of chronic diseases such as diabetes, rise in aging population,
Biosimulation Market Shares, Strategies and Forecast Worldwide, 2016 to 2024
Global Biosimulation Market: Overview Biosimulation refers to the mathematical simulation of biological processes and systems. It is aided by computer and is used for model based calculation of biological systems and processes. TMR’s latest report forecasts strong growth for the global biosimulation market between 2011 and 2018. The market is expected to significantly gain from the increasing use of pharmacokinetic (PKPD) and pharmacodynamics, of which PKPD is the most widely used
Biosimulation Technology Market Worth US$ 2700 Million by 2022
New York, February 06: Market Research Engine has published a new report titled as “Biosimulation Technology Market By Application Analysis (Drug Discovery, Drug Development) and By Regional Analysis – Global Forecast by 2016 – 2022”. How Big is the Global Biosimulation Technology Market? The Global Biosimulation Technology Market is expected to exceed more than US$ 2700 million by 2022 and will grow at a CAGR of more than 15% in the given